Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Ketamine for Veterans With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the VA Office of Research and Development is evaluating ketamine as a treatment for Parkinson's disease in veterans; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease | Phase 2 | Status: RECRUITING